> top > docs > PMC:7536954 > spans > 2527-2676 > annotations

PMC:7536954 / 2527-2676 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T4 22-33 Body_part denotes left axilla http://purl.org/sig/ont/fma/fma45303

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T3 27-33 Body_part denotes axilla http://purl.obolibrary.org/obo/UBERON_0009472

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T38 60-62 Disease denotes HS http://purl.obolibrary.org/obo/MONDO_0006559

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T18 27-33 http://www.ebi.ac.uk/efo/EFO_0001395 denotes axilla
T19 114-115 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 146-147 http://purl.obolibrary.org/obo/CLO_0001021 denotes b

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T26 60-62 Chemical denotes HS http://purl.obolibrary.org/obo/CHEBI_74056

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
93 93-104 Chemical denotes secukinumab MESH:C555450

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T24 60-62 Phenotype denotes HS http://purl.obolibrary.org/obo/HP_0040154

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T23 0-149 Sentence denotes Manifestations at the left axilla consisted of inflammatory HS nodules and fistulas prior to secukinumab therapy (a) and after 20‐week treatment (b).